Team
Dr Darragh Colgan, CTO
Dr Darragh Colgan, CTO
Dr Darragh Colgan, CTO
Dr Darragh Colgan MBA PhD BEng, Co-founder and Chief Technical Officer, is a biomedical engineer that prior to joining Pumpinheart was Vice President R&D Structural Heart Boston Scientific (2013-2022) in Los Gatos, California and Galway, Ireland following other senior development positions at Boston Scientific in Minneapolis and Galway (1996-2012).
Dr Aamir Hameed, CMO
Dr Darragh Colgan, CTO
Dr Darragh Colgan, CTO
Dr Aamir Hameed, MBBS, MD, PgDipEd (Health Professions Education) - Co-founder and Chief Medical Officer of Pumpinheart - is a Lecturer with Department of Anatomy and Regenerative Medicine at the Royal College of Surgeons in Ireland – RCSI University of Medicine and Health Sciences. He is a Principal Investigator (PI) with the Tissue Engi
Dr Aamir Hameed, MBBS, MD, PgDipEd (Health Professions Education) - Co-founder and Chief Medical Officer of Pumpinheart - is a Lecturer with Department of Anatomy and Regenerative Medicine at the Royal College of Surgeons in Ireland – RCSI University of Medicine and Health Sciences. He is a Principal Investigator (PI) with the Tissue Engineering Research Group (TERG) within RCSI and Trinity Centre for Biomedical Engineering (TCBE) within Trinity College Dublin (TCD) and has been a Visiting Scientist at HCA Healthcare Houston and MIT Boston, US. Dr Hameed has a background in Cardiothoracic Surgery and invented this diastolic heart pump, ‘PReduction’ in 2018’.
Donald Hickey, CEO
Dr Darragh Colgan, CTO
Dr Andrew Malone, CSO
Donald Hickey MDes(RCA) BABAI HDip(CompSci) DipAF(ACCA), Co-founder and Chief Executive Officer of Pumpinheart, is a start-up business developer that previously co-founded various educational technology developers and has held other business development roles targeting medical device and pharmaceutical clinical research sectors. Qualifica
Donald Hickey MDes(RCA) BABAI HDip(CompSci) DipAF(ACCA), Co-founder and Chief Executive Officer of Pumpinheart, is a start-up business developer that previously co-founded various educational technology developers and has held other business development roles targeting medical device and pharmaceutical clinical research sectors. Qualifications include engineering, product design, software development and accounting.
Dr Andrew Malone, CSO
Dr Darragh Colgan, CTO
Dr Andrew Malone, CSO
Dr Andrew Malone PhD MSc BSc, Co-founder and Chief Scientific Officer, is a medical physicist that prior to joining Pumpinheart was a post doctoral researcher at the Royal College of Surgeons in Ireland (RCSI). Dr Malone develops the prototypes and the the bench testing simulators.
Dr Jeanne Bolger, Non-Executive Director
Paraic Curtis, Chairman and Non-Executive Director
Jonathan Bouchier-Hayes, Non-Executive Director
Corporate Venture Capital Investor, Johnson & Johnson Innovation - JJDC. 35 year veteran Pharma industry senior leader and registered medical doctor with over 20 years experience in Licensing, M&A, Business Development, Alliance Management and Venture Capital investment.
In the last 8 years , has been a Non-Executive Director on the Boar
Corporate Venture Capital Investor, Johnson & Johnson Innovation - JJDC. 35 year veteran Pharma industry senior leader and registered medical doctor with over 20 years experience in Licensing, M&A, Business Development, Alliance Management and Venture Capital investment.
In the last 8 years , has been a Non-Executive Director on the Boards of over a dozen companies, Chaired the Board and chaired or sat on Audit and Remuneration sub-committees, all in venture-backed Life Science companies.
Has participated in and led Series Seed, A, B and C financing rounds, managed portfolio companies to exit and to public listings.
Led strategic initiatives for Fund of Fund investing and represented company as LP in multiple VC funds. Sat on multiple industry advisory boards for public institutions in Medical Devices, Digital Health.
Investments have spanned Oncology, Neurology, Immunology, Psychiatry, micro biome research, gene therapy, rare disease, digital health and wellness.
Jonathan Bouchier-Hayes, Non-Executive Director
Paraic Curtis, Chairman and Non-Executive Director
Jonathan Bouchier-Hayes, Non-Executive Director
CEO, Endowave. Endowave is developing medical technology - a minimally invasive treatment for lung cancer, the most common cause of cancer deaths worldwide. Its unique technology features a low profile, flexible, microwave ablation probe to treat lung cancer bronchoscopically. Previously a Research Fellow at Bioinnovate Ireland and recipi
CEO, Endowave. Endowave is developing medical technology - a minimally invasive treatment for lung cancer, the most common cause of cancer deaths worldwide. Its unique technology features a low profile, flexible, microwave ablation probe to treat lung cancer bronchoscopically. Previously a Research Fellow at Bioinnovate Ireland and recipient of an Enterprise Ireland Commercialization Fund grant. The Fellowship programme is a specialist medical device innovation training programme, modelled on the prestigious Stanford BioDesign programme. and the genesis of the Endowave business.
Dr Faisal Cheema, Non-Executive Director
Paraic Curtis, Chairman and Non-Executive Director
Paraic Curtis, Chairman and Non-Executive Director
Director of Research, HCA Heathcare and Associate Professor University of Houston, College of Medicine. A prolific physician-scientist who specializes in basic sciences, translational and clinical research, Dr. Cheema is currently the Director of Research at HCA Research Institute in its Gulf Coast Division. In this role, he provides lead
Director of Research, HCA Heathcare and Associate Professor University of Houston, College of Medicine. A prolific physician-scientist who specializes in basic sciences, translational and clinical research, Dr. Cheema is currently the Director of Research at HCA Research Institute in its Gulf Coast Division. In this role, he provides leadership to clinical research in a consortium of 16 hospitals within Texas.
Paraic Curtis, Chairman and Non-Executive Director
Paraic Curtis, Chairman and Non-Executive Director
Paraic Curtis, Chairman and Non-Executive Director
CEO, TSC Endovision, (France) - a pioneer in single-use endoscopy - and previously acted as Senior Vice President and General Manager TE Connectivity, Medical; VP and GM of Boston Scientific MedSurg; as well as many other vice president and managing director positions at Boston Scientific.
ADVISORS
Prof Javed Butler MD, MPH, MBA Baylor Scott and White Research Institute, Dallas, TX, USA and the Patrick H Lehan Chair of Cardiovascular Research.
Prof Mark Spence MB BCh BAO (Honours) MD FRCP. Leads the structural heart program at Mater Private Network and participates in the research activities of the Cardiovascular Research Institute.
Prof Javed Butler MD, MPH, MBA Baylor Scott and White Research Institute, Dallas, TX, USA and the Patrick H Lehan Chair of Cardiovascular Research.
Ellen Roche PhD, Associate Professor at MIT School of Engineering
Prof Mark Spence MB BCh BAO (Honours) MD FRCP. Leads the structural heart program at Mater Private Network and participates in the research activities of the Cardiovascular Research Institute.
Prof Javed Butler MD, MPH, MBA Baylor Scott and White Research Institute, Dallas, TX, USA and the Patrick H Lehan Chair of Cardiovascular Research.
Prof Robert Byrne MB BCh PhD MRCPI FESC, Director of Cardiology at Mater Private Hospital, Chair of Cardiovascular Research, RCSI University of Medicine and Health Sciences
Prof Mark Spence MB BCh BAO (Honours) MD FRCP. Leads the structural heart program at Mater Private Network and participates in the research activities of the Cardiovascular Research Institute.
Prof Mark Spence MB BCh BAO (Honours) MD FRCP. Leads the structural heart program at Mater Private Network and participates in the research activities of the Cardiovascular Research Institute.
Prof Mark Spence MB BCh BAO (Honours) MD FRCP. Leads the structural heart program at Mater Private Network and participates in the research activities of the Cardiovascular Research Institute.
Prof Mark Spence MB BCh BAO (Honours) MD FRCP. Leads the structural heart program at Mater Private Network and participates in the research activities of the Cardiovascular Research Institute.
Prof Mark Spence MB BCh BAO (Honours) MD FRCP. Leads the structural heart program at Mater Private Network and participates in the research activities of the Cardiovascular Research Institute.
Dr Alastair Gray MB BCh BAO (Hons) MPharm Consultant Cardiologist, Southern Health and Social Care Trust and Mater Hospital Dublin, is widely published and involved in a number of international Heart Failure clinical trials, including first in human trials.
Dr Alastair Gray MB BCh BAO (Hons) MPharm Consultant Cardiologist, Southern Health and Social Care Trust and Mater Hospital Dublin, is widely published and involved in a number of international Heart Failure clinical trials, including first in human trials.
Dr Alastair Gray MB BCh BAO (Hons) MPharm Consultant Cardiologist, Southern Health and Social Care Trust and Mater Hospital Dublin, is widely published and involved in a number of international Heart Failure clinical trials, including first in human trials.
Tom Melvin MBBS LLM LLB, Associate Prof. Medical Device Regulatory Affairs, Trinity College Dublin
Dr Alastair Gray MB BCh BAO (Hons) MPharm Consultant Cardiologist, Southern Health and Social Care Trust and Mater Hospital Dublin, is widely published and involved in a number of international Heart Failure clinical trials, including first in human trials.
Dr Alastair Gray MB BCh BAO (Hons) MPharm Consultant Cardiologist, Southern Health and Social Care Trust and Mater Hospital Dublin, is widely published and involved in a number of international Heart Failure clinical trials, including first in human trials.
Mary Jo Braid-Forbes, M.P.H., President, Braid-Forbes Research
Dr Alastair Gray MB BCh BAO (Hons) MPharm Consultant Cardiologist, Southern Health and Social Care Trust and Mater Hospital Dublin, is widely published and involved in a number of international Heart Failure clinical trials, including first in human trials.
Derek John PhD, Technology Transfer Manager, RCSI University of Medicine and Health Sciences